USP16 and inflammatory bowel disease: A study demonstrated that USP16 enhances NF-κB activation by selectively removing K238-linked ubiquitination from IKKβ, thereby promoting p105 phosphorylation and exacerbating inflammatory responses in inflammatory bowel disease (IBD) [19].